Overexpression of monosialoganglioside GM3 on lymphocyte plasma membrane in patients with HIV infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 2, 1996, Pages 112-119

  Sorice, Maurizio ^a   Garofalo, Tina ^a   Sansolini, Tiziana ^a   Griggi, Tamara ^a   Circella, Annapia ^a   Massetti, Annapaola ^b   Tai, Tadashi ^a   Pavan, Antonio ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Antiganglioside antibodies; GM3; Plasma membrane

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM3; MONOSIALOGANGLIOSIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; INFECTION RISK; LIPID MEMBRANE; LYMPHOCYTE MEMBRANE; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029887111     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199606010-00003     Document Type: Article

References (32)

1. Lynn WS, Tweedale A, Cloyd MW. Human immunodeficiency virus (HIV-1) cytotoxicity: perturbation of cell membrane and depression of phospholipid synthesis. Virology 1988;163:43-51.
2. Apostolov K, Barker W, Galpin SA, Habib NA, Wood CB, Kinchington D. Syncytia formation in HIV-1 infected cells is associated with an increase in cellular oleic acid. FEBS Lett 1989;250:241-4.
3. Aguilar JJ, Anel A, Torres JM, Semmel M, Uriel J. Changes in lipid composition of human peripheral blood lymphocytes infected by HIV. AIDS Res Hum Retroviruses 1991;7:761-5.
4. + cells. AIDS 1992;6:332-3.
5. Klein A, Mercure L, Gordon P, et al. The effect of HIV-1 infection on the lipid fatty acid content in the membrane of cultured lymphocytes. AIDS 1990;4:865-7.
6. Aloia RC, Tian H, Jensen FC. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membrane. Proc Natl Acad Sci USA 1993;90: 5181-5.
7. Van Veldhoven PP, Matthwes TJ, Bolognasi BP, Bell RM. Changes in bioactive lipids, alkylacylglycerol and ceramide occur in HIV-infected cells. Biochem Biophys Res Commun 1992;187:209-16.
8. Sonnino S, Acquotti D, Kirschner G, Tettamanti G. Advances in ganglioside chemistry. In: Tettamanti G, Ledeen RW, Sandhoff K, Nagai Y, Toffano G, eds. Gangliosides and neuronal plasticity. New York: Springer Verlag, 1986: 17-46.
9. Misasi R, Sorice M, Griggi T, et al. GM3 as a target of anti-lymphocyte ganglioside antibodies in AIDS patients. Clin Immunol Immunopathol 1993;67:216-23.
10. Auci DL, Chise SM, Durkin HG, Murali MR. Constitutive production of PAI-II and increased surface expression of GM1 ganglioside by peripheral blood monocytes from patients with AIDS. Evidence of monocyte activation in vivo. J Leukocyte Biol 1992;52:282-6.
11. Kiguchi K, Henning-Chubb BC, Huberman E. Glycosphingolipid pattern of peripheral blood lymphocytes, monocytes and granulocytes are cell specific. J Biochem 1990;107:8-14.
12. Whisler RL, Yates AJ. Regulation of lymphocyte responses by human gangliosides: characteristics of inhibitory effects and the induction of impaired activation. J Immunol 1980; 125:2106-11.
13. Norihisa Y, McVicar DW, Ghosh P, et al. Increased proliferation, cytotoxicity and gene expression after stimulation of human peripheral blood T lymphocytes through a surface ganglioside (GD3). J Immunol 1994;152:485-95.
14. Sadiq SA, Thomas FP, Kilidireas K, et al. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 1990;40:1067-72.
15. Vitti V, Fenzi GP, Chiovato L, Marcocci G, Pinchera A. TSH receptor antibodies. In: Leb G, Passath A, Eber O, Hoefler N, Eds. Thyreotropin. Berlin: de Gruyter, 1987:307-17.
16. Dotta F, Colman PG, Lombardi D et al. Ganglioside expression in human pancreatic islets. Diabetes 1989;38:1478-83.
17. Sorice M, Lenti L, Misasi R, et al. Anti-glycosphingolipid antibodies in HIV infection. AIDS 1991;5:345-6.
18. Griggi T, Bauer R, Garofalo T, et al. Autoantibodies against ganglioside GM3 represent a portion of anti-lymphocyte antibodies in AIDS patients. Scand J Immunol 1994;40:77-82.
19. Kotani M, Ozawa H, Kawashima I, Ando S, Tai T. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim Biophys Acta 1992; 1117:97-103.
20. Leivestad T, Gaudernack G, Ugelstad J, Thorsby E. Isolation of pure and functionally active T4 and T8 cells by positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. Transplant Proc 1987;19:265-7.
21. Svennerholm L, Fredman PA. A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta 1980;617:97-109.
22. Williams MA, McCluer RH. The use of Sep-pak C18 cartridges during the isolation of gangliosides. J Neurochem 1980;35:266-9.
23. Jourdian GW, Dean L, Roseman S. A periodate-resorcinol method for the quantitative estimation of free sialic acid and their glicosides. J Biol Chem 1971;246:430-5.
24. Slot JW, Geuze HJ. Sizing of protein A-colloidal gold probes for immunoelectron microscopy. J Cell Biol 1981;90:533-6.
25. Furukawa K, Arita J, Satomi N, Eisinger M, Lloyd KO. Tumor necrosis factor enhanced GD3 ganglioside expression in cultured human melanocytes. Arch Biochem Biophys 1990;281:70-5.
26. Obeid LM, Linardik CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993;259: 1769-71.
27. Hakomori S, Kannagi R. Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst 1983;71:231-51.
28. Nores GA, Dohi T, Taniguchi M, Hakomori S. Density-dependent recognition of cell surface GM3 by a certain antimelanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen. J Immunol 1987;139:3171-6.
29. Lloyd KO, Gordon CM, Thampoe IJ, Di Benedetto C. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells. Cancer Res 1992;52:4948-53.
30. Sharom FJ, Grant CWM. A model for ganglioside behaviour in cell membranes. Biochim Biophys Acta 1978;507:280-93.
31. Rosner H, Greis CH, Rodemann HP. Density-dependent expression of ganglioside GM3 by human skin fibroblasts in an all-or-none fashion, as a possible modulator of cell growth in vitro. Exp Cell Res 1990;190:161-9.
32. Dorsett BH, Cronin W, Ioachim HL. Presence and prognostic significance of antilymphocyte antibodies in symptomatic and asymptomatic human immunodeficiency virus infection. Arch Intern Med 1990;150:1025-8.